Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer
December 19, 2024
December 19, 2024
BUFFALO, New York, Dec. 19 (TNSres) -- The Roswell Park Comprehensive Cancer Center issued the following news release:
* * *
Findings exploit tumor cell weakness stemming from mitochondrial unfolded protein response
Highlights
* Findings from new preclinical study reported in Oncogene
* Work helps explain why advanced prostate tumors may resist current treatments
* HSP60 inhibition emerges as promising treatment strate . . .
* * *
Findings exploit tumor cell weakness stemming from mitochondrial unfolded protein response
Highlights
* Findings from new preclinical study reported in Oncogene
* Work helps explain why advanced prostate tumors may resist current treatments
* HSP60 inhibition emerges as promising treatment strate . . .